HALOZYME THERAPEUTICS INC - NOTE 0.250% 3/0

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 0.250% 3/0
Principal, excl. options Q3 2024
686M
Holdings value Q3 2024
$688M
Value change Q3 2024
-$134M
Grand Portfolio weight change Q3 2024
0%
Number of holders
53
Number of buys Q3 2024
27
Number of sells Q3 2024
-27
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $686M $688M -$134M $1.00 53
2024 Q2 $833M $796M +$12.8M $0.95 57
2024 Q1 $635M $563M -$345K $0.89 59
2023 Q4 $631M $546M +$11.6M $0.86 61
2023 Q3 $615M $522M +$8.76M $0.84 62
2023 Q2 $607M $506M +$19.7M $0.83 64
2023 Q1 $649M $550M +$86.1M $0.85 60
2022 Q4 $443M $429M -$32.5M $0.97 52
2022 Q3 $478M $406M -$209M $0.85 46
2022 Q2 $713M $631M +$142M $0.88 49
2022 Q1 $543M $476M +$476M $0.88 45